Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4A | O75164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6079499 | 0.89 | ALDH1A1 (0.41) | KDM4AMEN1KMT2A | |
| SCHEMBL6080144 | 0.87 | KDM4E (0.43) | KDM4AMEN1KMT2A | |
| SCHEMBL6080164 | 0.80 | HRH4 (0.46) | HRH4 | |
| SCHEMBL6080384 | 0.76 | KDM4E (0.46) | KDM4AMEN1KMT2A | |
| SCHEMBL6080015 | 0.76 | ALDH1A1 (0.40) | MEN1KMT2A | |
| SCHEMBL6591671 | 0.74 | KDM4A (0.48) | KDM4AMEN1KMT2A | |
| SCHEMBL6080749 | 0.73 | CYP1A2 (0.54) | KDM4AKMT2A | |
| Hydrochloric Acid SCHEMBL6079508 | 0.73 | KDM4A (0.47) | KDM4AMEN1KMT2A | |
| SCHEMBL6080761 | 0.72 | MAPT (0.47) | MEN1KMT2A | |
| SCHEMBL27472343 | 0.70 | NCF1 (0.47) | MEN1KMT2AHRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060183909-A1 | Compositions derived from quinoline and quinoxaline, preparation and use thereof | NEURO3D (FR) | 2006-08-17 | — | — | US | claimed |
| US-20060183909-A1 | Compositions derived from quinoline and quinoxaline, preparation and use thereof | NEURO3D (FR) | 2006-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060183909-A1 | Compositions derived from quinoline and quinoxaline, preparation and use thereof | NQO1, NQO2, RECQL | KDM4A 849/4885MEN1 740/4885KMT2A 1384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.